IRIS
BACCARANI, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.156
EU - Europa 4.839
AS - Asia 1.136
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 5
SA - Sud America 3
OC - Oceania 1
Totale 23.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.063
UA - Ucraina 1.651
DE - Germania 1.191
CN - Cina 786
IT - Italia 713
FI - Finlandia 525
IE - Irlanda 316
TR - Turchia 175
SE - Svezia 167
CA - Canada 90
BE - Belgio 80
GB - Regno Unito 74
VN - Vietnam 69
IR - Iran 49
FR - Francia 46
RU - Federazione Russa 41
IN - India 36
EU - Europa 20
NL - Olanda 9
KR - Corea 7
TW - Taiwan 6
EG - Egitto 4
PL - Polonia 4
RO - Romania 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
EE - Estonia 2
ES - Italia 2
HR - Croazia 2
LI - Liechtenstein 2
MD - Moldavia 2
PA - Panama 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
SG - Singapore 1
TH - Thailandia 1
Totale 23.160
Salva come PNG Salva come JPEG
Città #
Fairfield 2.735
Woodbridge 1.814
Houston 1.291
Jacksonville 1.164
Chandler 1.158
Ashburn 1.106
Wilmington 1.075
Seattle 1.035
Cambridge 977
Ann Arbor 924
Dearborn 760
Udine 472
Beijing 383
Princeton 329
Dublin 316
Izmir 171
San Diego 151
Brussels 80
Hefei 76
Dong Ket 69
Ottawa 68
Norwalk 56
Des Moines 54
Nanjing 49
Kunming 45
Philadelphia 41
Boardman 38
Washington 28
Helsinki 25
Redmond 25
Jinan 23
Guangzhou 22
Leawood 22
Nanchang 21
Augusta 20
Grafing 19
Ardabil 18
Monmouth Junction 17
Toronto 17
San Mateo 16
Chengdu 15
Fuzhou 14
Milan 14
Zanjan 13
Simi Valley 12
Trieste 12
Phoenix 11
Ningbo 8
Redwood City 8
Shenyang 8
Hanover 7
Hebei 7
Rome 7
Xian 7
Zhengzhou 7
Auburn Hills 6
London 6
Saint Petersburg 6
Shaoxing 6
Andover 5
Changsha 5
Murano 5
New York 5
Sacramento 5
Taipei 5
Wuhan 5
Baotou 4
Chongqing 4
Dallas 4
Indiana 4
Shanghai 4
Taizhou 4
Venezia 4
Xiamen 4
Bologna 3
Cairo 3
Charlotte 3
Frankfurt am Main 3
Hangzhou 3
Henderson 3
Kraków 3
Mumbai 3
Shenzhen 3
Torino 3
Agugliano 2
Amsterdam 2
Bengaluru 2
Chaoyang 2
Chisinau 2
Colle Umberto 2
Cormeilles-en-Parisis 2
Edinburgh 2
Falls Church 2
Fremont 2
Huzhou 2
Kish 2
Latina 2
Maserada Sul Piave 2
Messina 2
Modena 2
Totale 17.013
Salva come PNG Salva come JPEG
Nome #
null 220
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 182
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 163
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 149
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 148
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 145
A single-center experience of late retransplantation of the liver. 141
A comparative prospective study of two available solutions for kidney and liver preservation 140
La splenectomia laparotomica e laparoscopica 135
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 135
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 134
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 133
A Matched Pair Analysis of Multicenter Long-term Follow-up after Split Liver Transplantation with Extended Right Grafts 129
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 129
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 128
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 127
Differential proteomic analysis of hepatocellular carcinoma 126
Impact of new treatment options for hepatitis c virus infection in liver transplantation 126
Diaphragm rupture in a liver transplant patient under chronic immunosuppressive therapy with sirolimus: rare complication after liver transplantation 124
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 124
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 122
Donor safety in living donor liver donation: An Italian multicenter survey 122
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 119
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 118
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 118
Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool 116
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study 116
Transarterial chemoembolization does not harm the hepatic artery at transplantation 116
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 116
Liver transplantation from old donors into HCV and non-HCV recipients 115
Future of minimally invasive surgery 114
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 112
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 111
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 111
Quality-of-life assessment before and after liver transplantation. 111
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 111
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 110
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 109
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 109
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 109
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 108
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 108
null 107
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 106
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 106
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 106
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial 106
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 106
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 104
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 104
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 103
Technical solutions for venous outflow reconstruction in damaged liver grafts during procurement: Case reports 103
Acute pancreatitis after kidney transplantation. 101
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 101
Single-time kidney transplantation and monolateral nephrectomy for hypertension and antihypertensive therapy in renal transplant recipients 101
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 101
Head and neck and esophageal cancers after liver transplant: Results from a multicenter cohort study. Italy, 1997-2010 99
Liver Transplant in Patients with HIV: Infection Risk Associated with HIV and Post-transplant Immunosuppression 99
Split and whole liver transplantation outcomes: A comparative cohort study 98
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: A case report 98
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 98
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 98
APURINIC APYRIMIDINIC ENDONUCLEASE/REDOX EFFECTOR FACTOR 1 IMMUNOREACTIVITY AND GRADING IN HEPATOCELLULAR CARCINOMA RISK OF RELAPSE AFTER LIVER TRANSPLANTATION 98
Long-term placement of subcutaneous Rusch-type stents for double biliary stenosis in a living-donor liver transplant recipient 97
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 97
IMMUNESUPPRESSION AND CANCER: A COMPARISON OF RISKS IN RECIPIENTS OF ORGAN TRANSPLANTS AND HIV-POSITIVE INDIVIDUALS 97
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 97
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 97
Laparoscopic versus open splenectomy in the management of splenomegaly: our preliminary experience 96
De novo malignancies after liver and kidney transplantations: A single center experience on 582 consecutive cases. 96
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 96
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 96
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 96
Perioperative intra- and extravascular volume in liver transplant recipients. 96
Selective bilirubin Removal by Plasma Treatment With Plasorba BR-350 for Early Cholestatic Graft Dysfunction 95
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 95
Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications 95
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 95
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 95
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 95
Early post-liver transplant surgical morbidity in HIV infected recipients: risk factor for overall survival? A nationwide retrospective study 95
Arterial rupture as the result of fungal arteritis after renal transplantation 94
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 94
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 93
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 93
A Simple Trick for Optimizing the Three-Vein Technique Outflow Anastomosis in Piggyback Liver Transplantation 93
Liver resection for hepatocellular carcinoma: A multivariate analysis of factors associated with improved prognosis. The role of clinical, pathological and surgical related factors 93
Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. 93
Pros and cons of liver transplantation in human immunodeficiency virus infected recipients 93
Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. 93
Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients 92
Appendicectomy and Crohn's disease: clinical and genetic associations 92
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 91
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 91
Role of cytomegalovirus and Epstein-Barr virus in patients with de novo colon cancer after renal transplantation. 90
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 90
Graft vessel wall pathology in a case of hepatic artery pseudo-aneurysm in a liver transplant recipient 89
CARDIOVASCULAR RISK FACTORS AND IMMUNOSUPPRESSIVE REGIMEN AFTER LIVER TRANSPLANTATION 89
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 89
Risk of cancer, following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe 89
Totale 10.949
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.118
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.803 0 0 186 32 19 18 27 306 18 422 1.063 712
2019/20207.693 406 401 284 1.082 629 1.208 925 864 592 623 237 442
2020/20214.354 117 473 138 472 284 505 315 534 593 170 515 238
2021/20222.537 109 280 73 128 36 97 168 139 34 472 604 397
2022/20232.706 360 216 41 340 240 708 27 178 344 39 90 123
2023/2024271 125 99 47 0 0 0 0 0 0 0 0 0
Totale 23.620